Primary percutaneous coronary intervention (PCI) is performed in approximately 85% of ST‐
segment elevation myocardial infarction (STEMI) cases that undergo coronary reperfusion in …

Primary percutaneous coronary intervention (PCI) and thrombolysis are approved therapies
in the treatment of ST-elevation myocardial infarction (STEMI). Many clinical trials have …

Background: Thrombolytic therapy is well established as first-line treatment in patients with
ST-segment elevation myocardial infarction (STEMI). However, primary percutaneous …

Keypoints: It is unclear what role, if any, intracoronary thrombolysis plays in the management
of ST-segment elevation myocardial infarction (STEMI) with primary percutaneous coronary …

Background: Several trials suggested superiority of primary percutaneous coronary
intervention (PPCI) angioplasty over thrombolysis in patients with ST-elevation myocardial …

Primary percutaneous coronary intervention (PPCI) is the treatment of choice for patients
with ST segment elevation myocardial infarction (STEMI). In the attempt to reduce the …

The advent of thrombolytic therapy was a major advance in the treatment of ST-segment
elevation myocardial infarction (STEMI). The administration of fibrinolytic reperfusion therapy …

Background Primary percutaneous coronary intervention (PPCI) is the preferred method of
reperfusion in ST-elevation myocardial infarction. However, microvascular perfusion is often …

ST-segment elevation myocardial infarction (STEMI) continues to be a significant public
health problem with more than 500,000 cases per year in the US [1]. The initial objective in …

Both thrombolysis and primary percutaneous coronary intervention (PCI) are validated
therapies in the treatment of ST-elevation acute myocardial infarction (STEMI). Primary PCI …